Drug: infliximab, recombinant Quarter: 2016Q3
Total Records: 276 Number of Pages: 14
| DRUGNAME | PT | EventCount |
|---|---|---|
| INFLIXIMAB, RECOMBINANT | Respiratory failure | 3 |
| INFLIXIMAB, RECOMBINANT | Retinal vein occlusion | 3 |
| INFLIXIMAB, RECOMBINANT | Tuberculosis | 3 |
| INFLIXIMAB, RECOMBINANT | Uveitis | 3 |
| INFLIXIMAB, RECOMBINANT | Vomiting | 3 |
| INFLIXIMAB, RECOMBINANT | Abdominal abscess | 2 |
| INFLIXIMAB, RECOMBINANT | Abdominal operation | 2 |
| INFLIXIMAB, RECOMBINANT | Abdominal pain | 2 |
| INFLIXIMAB, RECOMBINANT | Abscess | 2 |
| INFLIXIMAB, RECOMBINANT | Abscess limb | 2 |
| INFLIXIMAB, RECOMBINANT | Anal abscess | 2 |
| INFLIXIMAB, RECOMBINANT | Arthralgia | 2 |
| INFLIXIMAB, RECOMBINANT | Bladder cancer recurrent | 2 |
| INFLIXIMAB, RECOMBINANT | Blood disorder | 2 |
| INFLIXIMAB, RECOMBINANT | Breast cancer | 2 |
| INFLIXIMAB, RECOMBINANT | Bundle branch block left | 2 |
| INFLIXIMAB, RECOMBINANT | C-reactive protein increased | 2 |
| INFLIXIMAB, RECOMBINANT | Cardiovascular disorder | 2 |
| INFLIXIMAB, RECOMBINANT | Cataract | 2 |
| INFLIXIMAB, RECOMBINANT | Colorectal cancer | 2 |
Total Records: 276 Number of Pages: 14